Equity Overview
Price & Market Data
Price: $0.505
Daily Change: +$0.0209 / 4.14%
Range: $0.461 - $0.519
Market Cap: $9,254,295
Volume: 224,020
Performance Metrics
1 Week: -1.58%
1 Month: -6.68%
3 Months: -78.69%
6 Months: -79.88%
1 Year: -89.90%
YTD: -71.42%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.